Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...
Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment ...
IEEE Spectrum on MSN19h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Study Finds on MSN2d
Researchers uncover serious flaw in promising Alzheimer’s blood testsDamaged muscles in ALS patients release proteins previously linked only to brain disease In a nutshell Researchers discovered ...
ALS is fatal, usually leading to death within a few years from diagnosis, although more slowly progressing forms of the disease exist. Blood phosphorylated (p)-tau 181 and p-tau 217 have been ...
NEW YORK, March 04, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hu ...
For ALS, where approved treatments remain woefully limited, this acceleration addresses the urgent need to find therapies that meaningfully slow disease progression. The HEALEY Platform Trial ...
“She was also a proud educator.” While she was unable to sing in her later years due to having ALS, a progressive disease that affects the brain and spinal cord, Flack remained creative in ...
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, is a fatal, neurodegenerative illness that affects nerve cells in the brain and the spinal cord. The average life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback